COVID-19 危重病幸存者抑郁症和创伤后应激障碍症状的发生、并发和持续情况。

IF 4.2 2区 医学 Q1 PSYCHIATRY
Guillem Navarra-Ventura, Marta Godoy-González, Gemma Gomà, Mercè Jodar, Leonardo Sarlabous, Verónica Santos-Pulpón, Alba Xifra-Porxas, Candelaria de Haro, Oriol Roca, Lluís Blanch, Josefina López-Aguilar, Sol Fernández-Gonzalo
{"title":"COVID-19 危重病幸存者抑郁症和创伤后应激障碍症状的发生、并发和持续情况。","authors":"Guillem Navarra-Ventura, Marta Godoy-González, Gemma Gomà, Mercè Jodar, Leonardo Sarlabous, Verónica Santos-Pulpón, Alba Xifra-Porxas, Candelaria de Haro, Oriol Roca, Lluís Blanch, Josefina López-Aguilar, Sol Fernández-Gonzalo","doi":"10.1080/20008066.2024.2363654","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background:</b> Intensive care unit (ICU) admission and invasive mechanical ventilation (IMV) are associated with psychological distress and trauma. The COVID-19 pandemic brought with it a series of additional long-lasting stressful and traumatic experiences. However, little is known about comorbid depression and post-traumatic stress disorder (PTSD).<b>Objective:</b> To examine the occurrence, co-occurrence, and persistence of clinically significant symptoms of depression and PTSD, and their predictive factors, in COVID-19 critical illness survivors.<b>Method:</b> Single-centre prospective observational study in adult survivors of COVID-19 with ≥24 h of ICU admission. Patients were assessed one and 12 months after ICU discharge using the depression subscale of the Hospital Anxiety and Depression Scale and the Davidson Trauma Scale. Differences in isolated and comorbid symptoms of depression and PTSD between patients with and without IMV and predictors of the occurrence and persistence of symptoms of these mental disorders were analysed.<b>Results:</b> Eighty-nine patients (42 with IMV) completed the 1-month follow-up and 71 (34 with IMV) completed the 12-month follow-up. One month after discharge, 29.2% of patients had symptoms of depression and 36% had symptoms of PTSD; after one year, the respective figures were 32.4% and 31%. Coexistence of depressive and PTSD symptoms accounted for approximately half of all symptomatic cases. Isolated PTSD symptoms were more frequent in patients with IMV (<i>p</i>≤.014). The need for IMV was associated with the occurrence at one month (OR = 6.098, <i>p</i> = .005) and persistence at 12 months (OR = 3.271, <i>p</i> = .030) of symptoms of either of these two mental disorders.<b>Conclusions:</b> Comorbid depressive and PTSD symptoms were highly frequent in our cohort of COVID-19 critical illness survivors. The need for IMV predicted short-term occurrence and long-term persistence of symptoms of these mental disorders, especially PTSD symptoms. The specific role of dyspnea in the association between IMV and post-ICU mental disorders deserves further investigation.<b>Trial registration:</b> ClinicalTrials.gov identifier: NCT04422444.</p>","PeriodicalId":12055,"journal":{"name":"European Journal of Psychotraumatology","volume":"15 1","pages":"2363654"},"PeriodicalIF":4.2000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11185090/pdf/","citationCount":"0","resultStr":"{\"title\":\"Occurrence, co-occurrence and persistence of symptoms of depression and post-traumatic stress disorder in survivors of COVID-19 critical illness.\",\"authors\":\"Guillem Navarra-Ventura, Marta Godoy-González, Gemma Gomà, Mercè Jodar, Leonardo Sarlabous, Verónica Santos-Pulpón, Alba Xifra-Porxas, Candelaria de Haro, Oriol Roca, Lluís Blanch, Josefina López-Aguilar, Sol Fernández-Gonzalo\",\"doi\":\"10.1080/20008066.2024.2363654\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Background:</b> Intensive care unit (ICU) admission and invasive mechanical ventilation (IMV) are associated with psychological distress and trauma. The COVID-19 pandemic brought with it a series of additional long-lasting stressful and traumatic experiences. However, little is known about comorbid depression and post-traumatic stress disorder (PTSD).<b>Objective:</b> To examine the occurrence, co-occurrence, and persistence of clinically significant symptoms of depression and PTSD, and their predictive factors, in COVID-19 critical illness survivors.<b>Method:</b> Single-centre prospective observational study in adult survivors of COVID-19 with ≥24 h of ICU admission. Patients were assessed one and 12 months after ICU discharge using the depression subscale of the Hospital Anxiety and Depression Scale and the Davidson Trauma Scale. Differences in isolated and comorbid symptoms of depression and PTSD between patients with and without IMV and predictors of the occurrence and persistence of symptoms of these mental disorders were analysed.<b>Results:</b> Eighty-nine patients (42 with IMV) completed the 1-month follow-up and 71 (34 with IMV) completed the 12-month follow-up. One month after discharge, 29.2% of patients had symptoms of depression and 36% had symptoms of PTSD; after one year, the respective figures were 32.4% and 31%. Coexistence of depressive and PTSD symptoms accounted for approximately half of all symptomatic cases. Isolated PTSD symptoms were more frequent in patients with IMV (<i>p</i>≤.014). The need for IMV was associated with the occurrence at one month (OR = 6.098, <i>p</i> = .005) and persistence at 12 months (OR = 3.271, <i>p</i> = .030) of symptoms of either of these two mental disorders.<b>Conclusions:</b> Comorbid depressive and PTSD symptoms were highly frequent in our cohort of COVID-19 critical illness survivors. The need for IMV predicted short-term occurrence and long-term persistence of symptoms of these mental disorders, especially PTSD symptoms. The specific role of dyspnea in the association between IMV and post-ICU mental disorders deserves further investigation.<b>Trial registration:</b> ClinicalTrials.gov identifier: NCT04422444.</p>\",\"PeriodicalId\":12055,\"journal\":{\"name\":\"European Journal of Psychotraumatology\",\"volume\":\"15 1\",\"pages\":\"2363654\"},\"PeriodicalIF\":4.2000,\"publicationDate\":\"2024-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11185090/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Psychotraumatology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/20008066.2024.2363654\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/6/17 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"PSYCHIATRY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Psychotraumatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/20008066.2024.2363654","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/6/17 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0

摘要

背景:入住重症监护病房(ICU)和进行有创机械通气(IMV)与心理压力和创伤有关。COVID-19 大流行带来了一系列额外的长期压力和创伤体验。然而,人们对合并抑郁症和创伤后应激障碍(PTSD)知之甚少:研究 COVID-19 危重症幸存者中具有临床意义的抑郁症和创伤后应激障碍症状的发生、并发和持续情况及其预测因素:方法:单中心前瞻性观察研究,对象为入住重症监护室≥24小时的COVID-19成年幸存者。使用医院焦虑和抑郁量表的抑郁分量表和戴维森创伤量表对重症监护室出院后1个月和12个月的患者进行评估。分析了患有和未患有IMV的患者在抑郁症和创伤后应激障碍的独立症状和合并症状方面的差异,以及这些精神障碍症状发生和持续的预测因素:89名患者(42名IMV患者)完成了1个月的随访,71名患者(34名IMV患者)完成了12个月的随访。出院一个月后,29.2%的患者出现抑郁症状,36%的患者出现创伤后应激障碍症状;一年后,这两个数字分别为32.4%和31%。抑郁症状和创伤后应激障碍症状并存的患者约占所有症状病例的一半。IMV患者出现孤立的创伤后应激障碍症状的频率更高(p≤.014)。IMV需求与这两种精神障碍中任何一种症状在一个月内的发生率(OR = 6.098,p = .005)和12个月内的持续率(OR = 3.271,p = .030)相关:结论:在我们的 COVID-19 危重症幸存者队列中,合并抑郁症状和创伤后应激障碍症状的发生率很高。对 IMV 的需求预示着这些精神障碍症状的短期发生和长期存在,尤其是创伤后应激障碍症状。呼吸困难在IMV与重症监护室后精神障碍之间的关联中的具体作用值得进一步研究:试验注册:ClinicalTrials.gov identifier:试验注册:ClinicalTrials.gov 标识符:NCT04422444。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Occurrence, co-occurrence and persistence of symptoms of depression and post-traumatic stress disorder in survivors of COVID-19 critical illness.

Background: Intensive care unit (ICU) admission and invasive mechanical ventilation (IMV) are associated with psychological distress and trauma. The COVID-19 pandemic brought with it a series of additional long-lasting stressful and traumatic experiences. However, little is known about comorbid depression and post-traumatic stress disorder (PTSD).Objective: To examine the occurrence, co-occurrence, and persistence of clinically significant symptoms of depression and PTSD, and their predictive factors, in COVID-19 critical illness survivors.Method: Single-centre prospective observational study in adult survivors of COVID-19 with ≥24 h of ICU admission. Patients were assessed one and 12 months after ICU discharge using the depression subscale of the Hospital Anxiety and Depression Scale and the Davidson Trauma Scale. Differences in isolated and comorbid symptoms of depression and PTSD between patients with and without IMV and predictors of the occurrence and persistence of symptoms of these mental disorders were analysed.Results: Eighty-nine patients (42 with IMV) completed the 1-month follow-up and 71 (34 with IMV) completed the 12-month follow-up. One month after discharge, 29.2% of patients had symptoms of depression and 36% had symptoms of PTSD; after one year, the respective figures were 32.4% and 31%. Coexistence of depressive and PTSD symptoms accounted for approximately half of all symptomatic cases. Isolated PTSD symptoms were more frequent in patients with IMV (p≤.014). The need for IMV was associated with the occurrence at one month (OR = 6.098, p = .005) and persistence at 12 months (OR = 3.271, p = .030) of symptoms of either of these two mental disorders.Conclusions: Comorbid depressive and PTSD symptoms were highly frequent in our cohort of COVID-19 critical illness survivors. The need for IMV predicted short-term occurrence and long-term persistence of symptoms of these mental disorders, especially PTSD symptoms. The specific role of dyspnea in the association between IMV and post-ICU mental disorders deserves further investigation.Trial registration: ClinicalTrials.gov identifier: NCT04422444.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
7.60
自引率
12.00%
发文量
153
审稿时长
18 weeks
期刊介绍: The European Journal of Psychotraumatology (EJPT) is a peer-reviewed open access interdisciplinary journal owned by the European Society of Traumatic Stress Studies (ESTSS). The European Journal of Psychotraumatology (EJPT) aims to engage scholars, clinicians and researchers in the vital issues of how to understand, prevent and treat the consequences of stress and trauma, including but not limited to, posttraumatic stress disorder (PTSD), depressive disorders, substance abuse, burnout, and neurobiological or physical consequences, using the latest research or clinical experience in these areas. The journal shares ESTSS’ mission to advance and disseminate scientific knowledge about traumatic stress. Papers may address individual events, repeated or chronic (complex) trauma, large scale disasters, or violence. Being open access, the European Journal of Psychotraumatology is also evidence of ESTSS’ stand on free accessibility of research publications to a wider community via the web. The European Journal of Psychotraumatology seeks to attract contributions from academics and practitioners from diverse professional backgrounds, including, but not restricted to, those in mental health, social sciences, and health and welfare services. Contributions from outside Europe are welcome. The journal welcomes original basic and clinical research articles that consolidate and expand the theoretical and professional basis of the field of traumatic stress; Review articles including meta-analyses; short communications presenting new ideas or early-stage promising research; study protocols that describe proposed or ongoing research; case reports examining a single individual or event in a real‑life context; clinical practice papers sharing experience from the clinic; letters to the Editor debating articles already published in the Journal; inaugural Lectures; conference abstracts and book reviews. Both quantitative and qualitative research is welcome.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信